These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4881887)

  • 21. Various anti-motion sickness drugs and core body temperature changes.
    Cheung B; Nakashima AM; Hofer KD
    Aviat Space Environ Med; 2011 Apr; 82(4):409-15. PubMed ID: 21485398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the effectiveness of drugs for prevention of motion sickness].
    Galle RR; Gusakova GA; Sabaev VV; Galle NN
    Kosm Biol Aviakosm Med; 1988; 22(4):90-4. PubMed ID: 3066982
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological interventions for motion sickness: cardiovascular effects.
    Sunahara FA; Farewell J; Mintz L; Johnson WH
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Motion sickness].
    Naess K
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1764-5. PubMed ID: 5111147
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of efficacy of ginger with various antimotion sickness drugs.
    Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
    Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevention of motion sickness in orbital flight.
    Graybiel A
    Life Sci Space Res; 1976; 14():109-18. PubMed ID: 11977268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scopolamine alone or combined with ephedrine in seasickness: a double-blind, placebo-controlled study.
    Laitinen LA; Tokola O; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1981 Jan; 52(1):6-10. PubMed ID: 7011299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances].
    Radkevich LA
    Kosm Biol Aviakosm Med; 1977; 11(6):50-3. PubMed ID: 22775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some otological problems during space flight.
    Johnson WH
    J Laryngol Otol; 1971 Dec; 85(12):1246-8. PubMed ID: 5316139
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
    Collins WE; Schroeder DJ; Elam GW
    Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-emetic properties of 1-sulpiride in a ground-based model of space motion sickness.
    Miller JD; Brizzee KR
    Life Sci; 1987 Oct; 41(15):1815-22. PubMed ID: 3657384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The laboratory assessment of anti-motion sickness and anti-vertigo drugs.
    Barber HO; Basser W; Johnson WH; Takahashi P
    Can Med Assoc J; 1967 Dec; 97(24):1460-5. PubMed ID: 4863013
    [No Abstract]   [Full Text] [Related]  

  • 34. Another approach to motion sickness.
    Oenbrink RJ
    Postgrad Med; 1991 Nov; 90(6):44, 46. PubMed ID: 1946112
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antiemetics and emetics. 26].
    Sachweh H
    Pharm Prax; 1968; 6():140-5. PubMed ID: 4387824
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of drug countermeasures for space motion sickness on working memory in humans.
    Paule MG; Chelonis JJ; Blake DJ; Dornhoffer JL
    Neurotoxicol Teratol; 2004; 26(6):825-37. PubMed ID: 15451046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention and treatment of motion sickness].
    Marks E; Swiecicki W
    Wiad Lek; 1974 Jan; 27(1):37-42. PubMed ID: 4152152
    [No Abstract]   [Full Text] [Related]  

  • 38. [The treatment of seasickness with Kinetosin].
    May W
    Dtsch Gesundheitsw; 1965 Jul; 20(27):1234-6. PubMed ID: 5319776
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectivity of antimotion sickness drugs during artificial gravity simulations.
    Green JA
    Aerosp Med; 1973 Nov; 44(11):1255-60. PubMed ID: 4586812
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of some motion sickness suppressants on static and dynamic tracking performance.
    Schroeder DJ; Collins WE; Elam GW
    Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.